Refractive changes after intravitreal ranibizumab injections for diabetic macular oedema

ConclusionsIntravitreal ranibizumab injections did not seem to affect the refractive power of patients with diabetic macular oedema. Therefore, appropriate spectacle correction can be prescribed any time during ongoing treatment with ranibizumab injections.

Source: Clinical and Experimental Optometry - November 14, 2017 Category: Opthalmology Authors: Irini Chatziralli, Athanasios Chatzipantelis, Eleni Dimitriou, Evgenia Mpourouki, George Theodossiadis, Panagiotis Theodossiadis Tags: Research Source Type: research